Literature DB >> 11251425

Variations in expenditure between adult general intensive care units in the UK.

D L Edbrooke1, S A Ridley, C L Hibbert, M Corcoran.   

Abstract

This paper presents the findings from the second pilot study of the cost block method in 21 adult general intensive care units (ICUs). The aim of this study was to explore the possible reasons for the variation in cost identified in a previous pilot study of 11 ICUs. Data were collected for the six cost blocks for the financial year 1996/97. Multivariate analysis showed that 93% of the variation in expenditure on disposable equipment could be explained by the number of ICU beds, the number of admissions and the presence of a high-dependency unit (HDU). Ninety-two per cent of the variation in nursing staff expenditure was explained by the number of ICU beds and the presence of an HDU. Hospital type and the number of patient days explained 76% of the variation in expenditure on consultant staff. Sixty-four per cent of the variation in drug and fluid expenditure was explained by the number of patient days.

Entities:  

Mesh:

Year:  2001        PMID: 11251425     DOI: 10.1046/j.1365-2044.2001.01716.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  10 in total

1.  Comparative costing analysis of intensive care services between Hungary and United Kingdom.

Authors:  Akos Csomós; Mária Janecskó; David Edbrooke
Journal:  Intensive Care Med       Date:  2005-06-16       Impact factor: 17.440

2.  Variable costs of ICU patients: a multicenter prospective study.

Authors:  Carlotta Rossi; Bruno Simini; Luca Brazzi; Giancarlo Rossi; Danilo Radrizzani; Gaetano Iapichino; Guido Bertolini
Journal:  Intensive Care Med       Date:  2006-02-25       Impact factor: 17.440

Review 3.  [Sepsis in adult patients - definitions, epidemiology and economic aspects].

Authors:  O Moerer; M Quintel
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

4.  Costs and Utilization of Operating Rooms in a Public Hospital in Trinidad, West Indies.

Authors:  Seetharaman Hariharan; Deryk Chen
Journal:  Perm J       Date:  2015

5.  Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis.

Authors:  David L Edbrooke; Cosetta Minelli; Gary H Mills; Gaetano Iapichino; Angelo Pezzi; Davide Corbella; Philip Jacobs; Anne Lippert; Joergen Wiis; Antonio Pesenti; Nicolo Patroniti; Romain Pirracchio; Didier Payen; Gabriel Gurman; Jan Bakker; Jozef Kesecioglu; Chris Hargreaves; Simon L Cohen; Mario Baras; Antonio Artigas; Charles L Sprung
Journal:  Crit Care       Date:  2011-02-09       Impact factor: 9.097

6.  Cost of intensive care in a Norwegian University hospital 1997-1999.

Authors:  Hans Flaatten; Reidar Kvåle
Journal:  Crit Care       Date:  2002-12-18       Impact factor: 9.097

7.  A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units.

Authors:  Onnen Moerer; Enno Plock; Uchenna Mgbor; Alexandra Schmid; Heinz Schneider; Manfred Bernd Wischnewsky; Hilmar Burchardi
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.

Authors:  Alex Macario; John L Chow; Franklin Dexter
Journal:  BMC Med Inform Decis Mak       Date:  2006-03-15       Impact factor: 2.796

9.  Changes in hospital costs after introducing an intermediate care unit: a comparative observational study.

Authors:  Barbara C J Solberg; Carmen D Dirksen; Fred H M Nieman; Godefridus van Merode; Martijn Poeze; Graham Ramsay
Journal:  Crit Care       Date:  2008-05-15       Impact factor: 9.097

10.  Factors associated with long intensive care unit (ICU) admission among inpatients with and without diabetes in South Western Sydney public hospitals using the New South Wales admission patient data collection (2014-2017).

Authors:  Uchechukwu L Osuagwu; Matthew Xu; Milan K Piya; Kingsley E Agho; David Simmons
Journal:  BMC Endocr Disord       Date:  2022-01-20       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.